Quantcast

Elsevier Properties SA Announces Winners of the 2011 Reaxys® PhD Prize

June 27, 2011

NEUCHATEL, Switzerland, June 27, 2011 /PRNewswire/ –

Elsevier Properties SA announces the winners of the Reaxys PhD Prize, a
competition for candidates currently studying for a PhD or having completed
a PhD within the last 12 months. The Prize recognizes research and
publication excellence in the fields of organic, organometallic and
inorganic chemistry.

Once again the prize attracted high quality applicants from around 300
brilliant young chemists from many of the leading chemistry schools in the
world. Submissions consisted of a representative peer-reviewed piece of
published research, a PhD Supervisor letter of recommendation and a CV. All
entries were closely scrutinized by a review board of over 50 renowned
international chemists from academia and industry chaired by Professors
Anthony Barrett, Barry Trost and Henry Wong. The review board judged the
entries for originality, innovation, importance to the field, applicability,
rigor of approach and publication quality.

From the initial submissions, 45 finalists were selected (see
http://prize.reaxys.com/ for details of all the finalists). A further
review, carried out personally by the Chairs of the Review Board, then
identified the final three out of these 45. As a result, the winners of the
2011 Reaxys PhD Prize can now be announced as:

– Vikram Bhat, University of Chicago, USA:

Total Synthesis of N-Methylwelwitindolinone D Isonitrile (JACS 2011)

– Steven Malcolmson, Boston College, USA:

Highly Efficient Molybdenum-Based Catalysts for Enantioselective Alkene
Metathesis (Nature 2008)

– Dixit Parmar, University of Manchester, UK:

Reductive cyclisation cascades of lactones using SmI2-H2O (JACS 2011)

Professor Trost said, “For my co-chairs and me, making a final choice of
just three winners out of these 45 truly world-class young chemists was
extraordinarily difficult. The quality and dedication apparent in these
candidates makes me extremely optimistic that the future of our discipline
will be in safe hands.”

David Evans PhD, Scientific Affairs Director at Elsevier Properties SA
added, “It is a great privilege and honour to be involved with the Reaxys
PhD Prize as it is fast becoming the most prestigious and hotly contested
competition of the year for young chemists. To win the prize or to be
selected as a finalist is indeed recognition of excellence, creativity and
commitment. I am greatly looking forward to our Prize Symposium in Bangkok
and to the opportunity to get to know these successful candidates who, I am
sure, have very bright futures ahead of them.”

The three winners and 42 other finalists have each been invited to
attend the Reaxys PhD Prize Symposium at the 14th Asian Chemical Congress in
Bangkok, Thailand on Wednesday 7 September 2011, with travel bursaries and
free conference registration provided by Reaxys(R). The winners are invited
to give a short oral presentation of their research, and the finalists will
participate in a special poster session and reception. The symposium will
also feature presentations from Professors Henry Wong and Anthony Barrett.

About Elsevier Properties SA
Elsevier Properties SA is a center of excellence within Reed Elsevier for
the management of intellectual property. Elsevier Properties SA owns the
PharmaPendium and Reaxys databases. Trademarks including Reaxys(R),
PharmaPendium(TM) and The Lancet(R) are owned and protected by Elsevier
Properties SA and used under license. About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier’s online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai’s Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).

        Media contact
        Harald Boersma
        Senior Manager, Corporate Relations
        Elsevier
        +31-20-485-27-36
        H.boersma@elsevier.com

SOURCE Elsevier


Source: newswire



comments powered by Disqus